AddNeuroMed - Clinical Workpackage - Plasma based biomarkers for Alzheimer's Disease. | C4C
AddNeuroMed is a long term cohort study looking to identify biomarkers (biological signs of a disease) in Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD), where patients will be assessed over a long period of time to try and identify biomarkers that predict progression from MCI to AD.